Pack de 10 frascos6 em stockPoupe 26%PT-141 10 mg
Agonista da melanocortina bremelanotida
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Apenas para uso em investigação. Este composto é vendido estritamente para investigação in vitro e fins laboratoriais e não se destina ao consumo humano nem a uso terapêutico. Ao comprar, confirma que é um investigador qualificado e aceita o nosso aviso legal completo.
Restam apenas 6 packs
Agonista sintético dos recetores da melanocortina, estudado pelos efeitos sobre as vias neurais associadas à resposta sexual em aplicações de investigação.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mecanismo
A investigação sugere agonismo primário de MC4R, com efeitos no sistema nervoso central sobre marcadores neuroquímicos em sujeitos de estudo.
Verificado por HPLC face a uma especificação de pureza ≥99 %. Testado de forma independente por laboratórios terceiros acreditados.
PT-141 — perguntas frequentes
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Guias relacionados com PT-141
Os investigadores também exploram
Em destaquePack de 10 frascosPoupe 17%HGH
Pó liofilizado10 IU · 4 strengths
Hormona de crescimento humana recombinante
Em 2 combinações
Pack de 10 frascosPoupe 18%Tesamorelin
Pó liofilizado10 mg · 3 strengths
Análogo estabilizado de GHRH
Em 1 combinação
Em destaquePack de 10 frascosPoupe 22%CJC-1295 + Ipamorelin
Pó liofilizado5 mg + 5 mg
Combinação clássica de GHRH + mimético da grelina
Em 2 combinações